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I.

INTRODUCTION

The inhibitory effect of some anesthetic agents on mono¬
saccharide uptake in human erythrocytes has been demonstrated by
Greene (21).

The study here reported demonstrates that one

of these gases6 halothane, is taken up less rapidly by galactoseloaded than by control erythrocytes.

Galactose is believed to

pass across red cell membranes by a carrier mechanism common
to several monosaccharides.

This study is offered as evidence

that halothane may be transported across human red blood cell
membranes by the monosaccharide carrier mechanism in addition
to simple diffusion.

.

2

Membrane permeability

(10)

Permeation of the cell membrane by water or solutes may
occur in a variety of modes.

The least complex of these, simple

diffusion, dictates that water and solutes move through a mem¬
brane as free molecules in response to an osmotic or electrochemical
gradient.

Concentration, molecular or ionic size, hydration, val¬

ence, and molecular solubility in membrane lipid all influence the
ability of solute particles to cross the cell membrane by simple
diffusion

(17).

metabolic energy,

Although this mode of diffusion is independent of
a characteristic of erythrocyte monosaccharide

transfer, it cannot be wholly responsible for sugar passage in the
human red cell membrane.

A number of observations support the con¬

cept of a mobile carrier molecule within the erythrocyte membrane
which conveys monosaccharides fro® the external to the internal
surface under transport rates and conditions incompatible with
simple diffusion.

Carrier transfer

Pick's Principle postulates a linear relation between transport
rate and concentration gradient under conditions of simple diffusion:

— - p (S)
dt

-<S)
e

where P is the permeability coefficient,
transfer, and

1

the rate of forward sugar

(S)g and (S)^ the extra- and intra- cellular concentra¬

tions of the sugar.

If Pick’s Principle is applied to monosaccharide

transfer in the human erythrocyte, one finds that P is a variable
rather than a constant, and is inversely proportional to the concen-

3

tratlon gradient across the jiiezabrane,

At high monosaccharide con¬

centrations transport rate reaches a ?aaxiiBu®.
uration kinetics" further increase in (S)
in the apparent P.
the carrier.

©

In this state of ’ sat¬

is accompanied

by

a decrease

This la presumably caused by full utilisation

of

Unbound sugar then becomes essentially non-penetrating.

Carriage by simple diffusion is non-competitive’

that is,

increases in concentration of other monosaccharides do not affect
the transport rates of species under observation.
also known as facilitated diffusion,

Carrier transfer,

is competitive;

the transfer

rate for a given monosaccharide decreases in the presence of any of
a number of sterically similar sugars which compete for the carrier.

A further characteristic of simple diffusion is that elevation
of temperature produces relatively little change in transfer rate.
The exact ratio by which the velocity of a reaction changes when
subjected to a ten-degree centigrade rise in temperature Is refer¬
red to as the temperature coefficient or **Q^?

While this value

is close to 1 for the diffusion of small molecules through inert
membranes, it approaches or exceeds 2 for enzyme- or carrier- dep¬
endent transfer through biologically active membranes.

The

for glucose penetration into erythrocytes has been calculated at
from 2.5 to 6.25 by the investigators reviewed by Cronau (8).
The observation that monosaccharides may cross the erythrocyte
membrane against a concentration gradient is the most conclusive
demonstration of the inadequacy of simple diffusionto explain sugar
transport.

In addition, both this uphill transfer and diffusion

along concentration gradients occur without the expenditure of
metabolic energy.

Inhibition of glycolysis by ouabain has no

effect on monosaccharide transfer.

Jf 4

V
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Widdas

(69)

and Rosenberg and Wilbrandt

(58)developed

kinetic proofs that the energy required for ‘‘uphill transport'’
could be dervived from the simultaneous ’’downhill8’ movement
of a second substrate, sharing the same carrier but moving
across

the membrane In the opposite direction.

This has since been

accepted as a characteristic of the carrier system; such '"'counterflow” has been shown even in the absence of ,!uphill!< transport.

The monosaccharide carrier system

Widdas

(69) notes that Kozawa had observed in 1914 that glucose

penetrated erythrocytes rapidly, while methyl glucoside was
non-penetrating.

Ege

(

) observed that the rate of penetration

of glucose was reduced at high concentrations.

Wilbrandt(

)

found rapid penetration of B-xylose and L-arabinose but little
penetration by the stereoisomers L-xylose and D-arabinose.

The

rapidly transferred species were also mutually competitive inhibi¬
tors.

Similar studies by Le Fevre and Davies demonstrated compet¬

itive inhibition among stcrically similar monosaccharides but dem¬
onstrated that sorbose and fructose entered only by simple diffusion
kinetics(

).

Widdas found that fructose and sorbose traversed the

erythrocyte membrane by simple-diffusion kinetics, but observed in¬
hibition of this ketose transfer by glucose
studies

(

(

).

Earlier

) had demonatrated variation of the permeability coefficient

of glucose in a manner consistent with saturation of a biologic car¬
rier (

).

Joanny, Corriol, and Kleinzeller

(

) noted facilitated

diffusion in in vitro preparations ofguinea pig cerebral cortex,
and demonstrated saturation kinetics,

competitive inhibition, and

stereospecificity similar to that seen in primate erythrocytes.
Joanny and Corriol

(

) were unable to demonstrate inhibition of

this process by ouabain.

Facilitated diffusion of glucose is also

,
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present in dog and rat brain tissue(15)(37).

In other biologic systems, monosaccharide carrier systems
have been found in the rat diaphragm(44)„the isolated perfused
rat heart

(44), the sheep placenta

(68), erythrocytes of the fetal

guinea pig and other non-primate fetuses
tumor cell

(32),

(11), and the Erlich ascites

Studies of the intestinal mucosa of the dogfish

shark by Head (56) demonstrated inhibition of cycloleucine transport
by either preincubation or simultaneous ten-minute incubation with
galactose, although this carrier system is evidently
endent.

Gilbert has found transport, possibly active, of xylose

against a concentration gradient in the rat
brain.

energy-dep¬

(19) and guinea pig

(18)

Active transport of glucose or other monosaccharides has

been demonstrated in the guinea pig intestine

(51) and active reab¬

sorption of some sugars occurs in renal tubules
Michaljanicova

(34)

(63),

Kotyk and

andkotyk and Haskovec (33) have shown that

Saccharomyces cerevisiae

(baker’s yeast)

contains two constitutive

monosaccharide carriers and a third (inducible)

carrier for galactose.

Steveninck and Dawson (66) have also found two modes of galactose
transfer in baker *a yeast.

They state that in uninduced cells

transfer is mediated passively via a carrier and is not pH-dependent;

induced cells demonstrated highly pH-dependenfc active transport

which may share the same carrier.

Monosaccharide transfer across the erythrocyte membrane is
inhibited by a variety of compounds.
benzene,

Dinitrophenol, dinitrofluoro-

thymol, phloretin, phenolphthalien, and stilbesterol are

demonstrated inhibitors
demonstrated.

(16,

39);

their reversibility has not been

Mercuric chloride and p~chloromercuribenzoate inhibit

glucose transfer by combining with sulfhydryi groups.

Glucose transfer

6

frcm the cytoplasm to the surrounding medium is also impaired by
these agents.

Tine addition of cysteine reverses inhibition by

mercurials.

Hunter

(29) describes butanol inhibition of monosaccharide

transfer* but this was not confirmed by Greene and Cervenko

(22)

using methods similar to those employed in the present stud}’'.
Hagland

(24) has shells that butanol increases the rates of per-

me at ion of coalosie eggs of Rana temperia by water;,
toxic concentration of butanol was approached,

as the minimum

the permeability co¬

efficient for water approached infinity* suggesting the elimination
of a diffusion barrier.

This suggests that osmotic phenomena in

the presence of butanol may not fee a reliable indication of carrier
activity.
of glycerol

Copper ion has produced inhibition of carrier transfer
(7^)*

Oski, Root,

and Winegrad

(46) found erythro¬

cyte glucose consumption unaffected by the presence of insulin,
but demonstrated a 32.9

to 59 per cent decrease in the presence

of purified human growth hormone at a concentration of 16 ug/ml.
Fructose consumption fell 44,7% under similar conditions. Carbon
dioxide consumption remained constant despite inhibition of uptake,
and the concentration of fructose-6-phosphate and glucose-6-phosphate
underwent identical rises in both .experimental and control prepara¬
tions.

This suggests that alteration of monosaccharide transfer

in erythrocytes has little if any effect on the rate of monosaccha¬
ride metabolism.

Insulin increases transport capacity for glucose thirteenfold
in the isolated perfused rat heart, in which membrane kinetics are
the same as in erythrocytes, but this is reflected by increased
phosphorylation (,-Q).

In preparations of evisceratedt nephrectoaized

dogs, Levine, Goldstein, Muddlestun and Klein (40) demonstrated an
insulin-stimulated increase in galactose uptake, despite the fact

5
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that no transformation of galactose appeared in tissue*
dog erythrocyte is impermeable to galactose, however.
Regen and Park

The

Morgan,

(44) have noted counterflow of membranal glucose

in the presence of extracellular 3-0-methylglucose in the rat
diaphragm,

and have noted acceleration of the same phenomenon in

isolated perfused heart muscle treated with insulin.

They suggest

that insulin accelerates transfer by the mobile membrane carrier.
Langdon and Sloan

(35) state that insulin increases the number of

specific sugar-binding sited in the rat ependymal fat cell.

Carbon dioxide increases
human erythrocytes.

Greene

the rate of glucose transfer in
(21) has theorized that carbon dioxid e

might increase the number of operable carrier sites or act to
increase the affinity for the carrier at the external membrane sur¬
face;

it might alternatively, he states,

increase the rate of

dissociation of glucose-carrier complexes at the inner surface of
the membrane.

LeFevre

(38) has postulated an upper limit of 500,000 carrier

sites per erythrocyte membrane, but Stein has calculated that one
million sites are present on the basis of the number of dinitrophenyl residues necessary to completely label the carrier (65).

Membrane Kinetics
Lineweaver and Burk

(41) presented graphic adaptations of

the MichaeliS“Menten equation to various equilibria attainable
in enzymic systems.

The substitution of carrier rather than enzyme

molecules does not change the Lineweaver-Burk derivations, and they
have been used to characterize the monosaccharide transport system.

Those cases considered in monosaccharide transfer studies

r .

i

*
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are summarized below,

the original case numbers of Lineweaver

and Burk, but with the aubstituion of a carrier for an enzyme.

The original Mlchaelis-menten equation is;
V « v
(S)/ (K +(S) }
max
s
v « the velocity of the reaction

where;

v
« the maximal ve loci tv attainable by the reaction,
raax
(8) * substrate concentration

K

(in this case,

of mono¬
saccharide)

«= the substrate concentration which produces halfmaximal velocity (Michaelis constant);
This also the dissociation constant;

s

(CS)

Carrier
Cohcentration

Cage I.
C + S # CS

(where C represents one carrier molecule,
and S one substrate molecule.)

V
s

1/V

V

max

(S) + 1/V

max

Tills equation applies

in the case that one carrier molecule

accepts one sugar molecule and the complex is the active
species.
The plot of I/v against 1/(S) is a straight line.
The ordinate intercept is I/V
and the slope is K /V
max,
s
max.

Case II.

C + nS f CS
v » V
IT2St3&

n

(S)n/

(K

4- (S)B )
S

In this case, one or more sugar molecules are bound to each
carrier.

A plot of I/v against

(S)n yeilds a straight line.

The ordinate intercept and slope have the sane significance
as in Case I, but Kg is now the nth power of the substrate
at half “-maximal velocity.

This equation only applies when

the carrier binds a constant number of substrate molecules.
See Case V,

V

f

■

■

i

■ i •

9

In cases in which each component of the ratio (C£n)/(C)

can be

evaluated experimentally, the equation;
(CS )/(C) « (C)n/K
a
s
may be translated tc linear form by taking the log of both sides.
The slope of the plot of log
value of

(CS^)/(C) against log

equal to unity in the simplest case,

(S) is the

and the inter¬

cept at S * 1 is the log

In that of the red cell membrane,,

the cbserved velocity is the

difference between the inward and the outward transfer of mono¬
saccharide.

V a V

max

UB/
&

(K

3

(S D

—

>

v *= V

V

r
max

(S,}n/<Iv
1
s

n
nN
(bi> }

(s^11

max

Ks

($,)n
1

Employment of the "relative substrate concentration” defined as
the ratio of the substrate to the dissociation constant on each
side of the membrane enables the following substitution;

< SV° = <VX
V « V

max

(s O -)n
V

(Sj')”!

may be thought of a3 a consequence of two factors,

capacity of the membrane carrier,
The carrier saturation factor is

the

and its state of saturation.
the difference between two degrees

10

of saturations possible in the system*
carrier is
saturated.

fully saturated,

and 0,

I,

Indicating that the

indicating that it is not fully

Increasing the number of sugar moieties carried fro®

mono complex to dicomplex has no influence on the V

r

because it

max

is predicated experimentally upon full saturation.

The capacity of the membrane carrier is determined by the
permeability constant and the total carrier available, Cfc.

The

relationships which obtain between these factors are:
Capacity «

(permeability constant) x

Saturation factor

*

(C^)

1

* s.£. x capacity » capacity
under the condition that the diffusion constant of
the free carrier is equal to the carrier - sugar
complex.

CASE IV

2C + S + I

CS

(active)

Cl

+

(inactive)
"1

-i

I/v -

(I/V

max

>

(K

X
S

I/(S)

(i)

8

*4

I/V

max

-

Thit describes both competitive and non competitive
inhibition.

In each case the plot I/V against 1/(3)

is a straight line.

Comparing this to the straight line

form equation y*®urt-b one notes

that the term £ (!)/£_
S

i-

represents as additive increase in the slope; when this
term does increase the slope> V
is unchanged.
r
max
is Evidence of noncompetitive inhibition.
Competitive inhibition decreases

the V

Hi2i3£

This

directly by

lowering the number of sites available to substrate.
The slope is unchanged, but the ordinate intercept is
higher.

t
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Case VII.
S —S’

s(steady state(S')

),

S? C

CS

spheres
S~>S?

represents rate-limiting diffusion with a

velocity constant of k

V

*

V^k4

max

kjCS)

- v

This applies in the case of a rate-l.isd.ting step
preceding the carrier-sugar stag®.

This limit

may be that of diffusion or of a chemical process.

Although the rate-limiting step in the monosaccharide transfer
system has usually been characterized as the formation or diffusion
of the sugar-carrier complex*

there is no assurance that the

separation of the carrier complex from the aqueous lipid inter¬
ference is not isore difficult.

12

Merab rase kinetics - II.
Definition of the kinetics of glucose transfer based on the
assumption that the glucose-carrier complex crossed the
erythrocyte membrane slowly were developed by hTiddas.(68)
Rosenberg and Wilferandt

Later

(58) developed kinetics applicable to

systems with rate-limiting steps.

Each of these was based on.

the assumption that the sugar-carrier complex was a monocomplex ,
that is,

that each carrier molecule bound only one sugar molecule.

Subsequent observations of glycerol transport and transport of
pairs of different monosaccharides by Stein (64,65) suggested
dimer formation by enzymatic action or diccmplexes in which the
carrier molecule bound two sugar moieties,

Wilbrandt and.

Kotyk (71) confirmed Stalnfs postulate using nonisotopic sugars
added to erythrocyte preparations previously incubated with
isotopic solutions of the same monosaccharides.

Cronau

(8)

found that for all theoretical cases of the dicoaplex carrier
syste®s

the kinetics of the initial rate calculated could be

approximated by assuming a first-order process as in the son©complex carrier system.

Miller has since proposed the existence

of either pores or a membrane flanked on each side by a firstorder slow diffusion layer.

(52) Weinstein and Koo (67) have

shown particles extending completely through, and associated
with discontinuities of,

the erythrocyte membrane.

The most widely held and most completely investigated theory
continues to be that of a mobile earlier which probably binds two
molecules of monosaccharides.

Predominance of dicoraplexss may

be due to either higher mobility or preferential formation.

Molecular binding of sugars
Bobinski and Stein (4), working with Bonaall and Hunt,

(5)

have prepared chromatographic columns in which the stationary

13

phase is composed of ghost erythrocyte membranes.

These were

adsorbed onto Celite or BEAE-cellulose and displayed the mono¬
saccharide-transfer properties of erythrocytes.

Transport of

sugars on these columns was inhibited by phloretin and dinitrofluorobenzene.

Elution of these columns with a linear gradient

of half-molar sodium phosphate at pH 7 yielded five major peaks.
The second of these peaks was extracted by molar sodixasi iodide
from ghost® and was associated with 60% of the retardation of
glucose flow on the membrane-coated columns.

Langdon and Sloan

(11)

found that imine bonds formed between monosaccharides and the
lysyl residues of human erythrocyte membrane proteins.

They

claimed that the dissociation constants of these sugar-proiein-imine
complexes resembled those proposed for sugar-carrier complexes.
They also found competitive inhibition by various monosaccharides
and other competitive inhibitors and suggested that the lysylbearing residues were monosaccharide carriers.
disputes this on kinetic grounds„

LeFevre

(36)

arguing that carrier sites

of lower affinity would, better account for the data.
LeFevre, Jung and Chaney (38)
of

constructed a three-layer model

the erythrocyte membrane using a U-tube.

of the tube contained chloroform;

The lower portion

aqueous phases representing

the internal and external cellular fluids were placed in the
U-tube arms.

'They found that passage of glucose across the chloro¬

form phase was markedly accelerated by the addition of any of
a variety ©f phospholipids but that the aqueous-membrane interfaces
presented the major barrier to diffusion.

At high glucose

concentrations the rate of transfer increased,,
dimerization.

suggesting

A crude lipid extract had greater affinityfor

ribose than glucose and transported inositol as well.

These

characteristics are not those of the erythrocyte carrier, which
transports glucose better than ribose and does not transport inositol.

.

<
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They suggest that, study of the purified fractions may disclose
different properties.

In the same paper,

the suggestion is made

that erythrocyte monosaccharide transfer may involve the serial part¬
icipation of two membrane elements;
Sugar 4- Surface reacting site

Surface complex

(? protein)

4
Fhospholipids

Mobile complex
(?ph©spholipid~sugar-protein)

A similar dissociation would occur at the inner membrane surface,
Anraku (15

2) has isolated a galactose-binding protein from

galactokina®e-lacking mutants of E,

coll K 12;

teins have a molecular weight of 35,000,
in a molar ratio ©£ 1;1.

these binding pro¬

and complex with substrate

Since the rate of galactose uptake exceeds

that explained by stoichiometric bonding,

turnover capability must

exist for the carrier,
kotyk and Michaljanicova (34) have isolated a monosaccharide¬
binding protein fom

Saccharomycas eereyisiae which is present in

the internal cellular fluid, but has no activity in membrane
transport.

They caution that this makes the study of kinetic data

difficult.

Although no similar study of the erythrocyte has

been located,
those of

the kinetics of red cell ghost membranes are

the intact cell.

Anesthetics and the erythrocyte membrane

Anesthetics exert two distinct,

although possibly related*,

effects on the erythrocyte membrane.

The first of these is

stabilization of the membrane against hemolysis
(61)

(6).

Seeraan

found that, thirteen aromatic and ten aliphatic alcohols,

all credited with anesthetic action,

stabilized the erythrocyte a~

gainst hypotonic hemolysis at lov? concentrations, but caused head-

■

.

; ‘ ,)

.

,

>
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ysls at higher concentrations.
Furthermore,

Nine steroids did likewise.

the concentration of alcohol which caused fifty

per cent stabilization was that found to be the minimum anesth¬
etic concentration (AR^q) by Meyer and Hemmi
of alcohols on tadpoles,

and Skou (62)

(42),

using a variey

, using alcohols,

thymol, menthol, or beta-naphthol on frog, sciatic nerve.

The

amount of membrane stabilization occurlng at a steroid concentration
of 7 x 10

correlated with the ARr„ for steroid anesthesia in
50

rats feund by P’an and Lauhach

(47).

Although high concentrations

of tertiary-amine local anesthetics and alcohols cause depolariza¬
tion of nerve fiber,

depolarization is found at the

for

propyl alcohol only and is not necessary to a blocking effect.
Skou also demonstrated a close parallel between the blocking
potencies of both tertiary amines and alcohols and their ability
to penetrate a monolayer of frog sciatic nerve lipids extracted with
benzene

(62),

Jacobs, Glassman,

and Parpart

(30)

found in 1935

that carbon dioxide stabilized the human and rat erythrocyte
membranes against temperature-induced hemolysis in solutions of is¬
otonic glycerol.

This was accompanied by an increase in magnitude

of the temperature coefficient
Rand

(55)

of strain,

(0^)

Rlyce^ol entrance.

demonstrated that hemolysis follows upon application

such as increase in surface area,

rather than of stress,

such as bending forces.
Greene and Cervenko

(22)

demonstrated a stimulatory effect of

carbon dioxide on glucose transfer in human red blood cells at
21-23°C.

Mercuric chloride inhibited the stimulatory effect of car¬

bon dioxide, but not to as great an extent as in control preparations
not treated with carbon dioxide.

Neither ouabain nor butanol influenced

glucose transfer in control or carbon dioxide treated red cells.
The anesthetic gases halothane, methoxyflurane, and diethyl ether
depressed, but did not eliminate,
carbon dioxide.

the acceleration produced by

I
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Eass demonstrated enhancement of labelled carbon dioxide
transfer across ghost erythrocyte membranes by bicarbonate ion (14).
This enhancement was inhibited by the carbonic anhvdrase in¬
hibitor acetazolimide in red cell ghosts, but not in whole blood.
Studies by Greene

(21) on the affect of both halotbane and

methoxyflurane on the transfer of a variety of monosaccharides
demonstrated a depressant effect on the transfer of L-sorbose,
D~rib©se, D-arabloose, and D-galsctose, but had no significant
effect on the transfer of D-fructose, L-arabinose, G~xylose, or
D-glncose.

Nitrous oxide also decreased galactose transfer,

while diethyl ether had a© effect on galactose uptake.

The effects

of the latter three gases on transport of other sugars were variable.
Wilbrandt and Rosenberg

(70) have distinguished between

penetrating and non-panetrating inhibitors of transfer systems,
la the presence of a non-penetrating inhibitor the competition
at the external surface is the dtermleant of inhibition. However,
in the presence of a competitive inhibitor which is penetrating,
the kinetics when the Inhibitor

(I) is present in equal concentrations

on each side of the membrane ares

, - v —$sy- <so*>

Uo') 1

j&a(S1«) «1')

1

In this case the anesthetic may set as a competitive inhibitor at
high concentration or may act to increase transfer of
the counterflow system previously discussed.

Thus,

via

the action of

a particular anesthetic upon monosaccharide transfer depends not
only upon the ease with which it penetrates the lipid membrane as

& simply-diffusing solute, but also upon its affinity for the carrier
molecule,
of

the ultimate concentration of anesthetic on either side

the membrane and the concentration gradient of the monosaccharide

under study.
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Halothane

Halothane anesthetic gas has been characterized by several inv¬
estigators (59) and the pertinent physical and chemical characteri¬
stics are summarized in Table 1.
Commercial halothane contains thymol in low concentration.
Balothane reacts with rubber and some plastics, but not with plyethylene.

Although sixteen trace contaminants were noted by Chap¬

man et al., none was present in a concentration of over 12 ppm.
(7).

At high temperatures in the presence of copper, halothane may

polymerize to form the cellulotoxic compound 2,3-dichloro~l,l»l»4,
4,4 hexafluorobut-2-ene.

Halothane is extremely soluble in lipid

as is methoxyflurane (63) but Greene found halothane to be more
inhibitory toward galactose transferthan was methoxyflurane.
Lipid solubility alone, therefore, cannot account for this inhibition.
Hans and Helrich (25) have reported the effect of temperature
on the solubility of halothane in human blood and in brain tissue
homogenates.

In human brain gray matter the tissue/air partition

coefficient of halothane increases in a curvilinear manner as temp¬
erature 4ecreases from normal to below 28°C.

In human whole blood

at 38°C and at a hematocrit of 50%, 70% of the halothane is
carried by plasma and 30% by blood cells.

If both hematocrit and

hemoglobin concentrations are increased the partition coefficient
decreases slightly, due to the greater solubility of halothane in
plasma than in red cells.

If the hemoglobin concentration is

increased independently of hematocrit, the partition coefficient
increases, suggesting hemoglobin binding of halothane.

Twelve

to twenty per dent of halothane admin-stered to humans as anesthesia
is metabolized (57).
Scholander (60) and others (13, 27, 28) have demonstrated facil¬
itated diffusion of oxygen through hemoglobin-saturated Milipore
filters.

This occurs after full saturation of hemoglobin (that is,

total conversion to oxy-hemoglobin) and may be due to exchange of

18

oxygen moleculesby collision of hemoglobin molecules.
However, oxygen crosses the erythrocyte membrane by simple
diffusion only.

19

III.

MATERIALS AND METHODS

Principle

Fresh human packed red cells were exposed to identical
atmospheres of room air during a one-hour incubation with
either galactose in phosphate buffer,,
only.

or phosphate buffer

The phosphate buffer was chosen for its support of mono¬

saccharide utilisation (57).

They were then exposed to ident¬

ical concentrations of fealothane in an instrument designed
to indicate the difference in volumes of halothane taken up
by the control and galactose-treated red cella.

Serial

determinations of the hematocrits in each of these solutions
and in similar suspensions not exposed to halothsac were
made and these were accepted as an osmotic index of
galactose penetration into red blood cells

(38*

39 9

71).

The supernatant was observed at each hematocrit determination
for presence of hemolysis.

Apparatus(Figure 1)

The differential manometer fabricated for these experiments
was based upon that designed by Winterstein in 1912
horizontal glass tube serves as

(72),

the manometer proper.

A

At each

end the manometer is joined to glass chambers of identical
shape and volume by polyethylene tubing and metal cannulae.
The bore of the manometer tube is lubricated with a soap sus¬
pension.

A small column of

this suspension moves freely in

response to pressure changes at either end.

Three-way stop¬

cocks feetw-en the manometer and the tubing allow connection
between the glass chambers via the manometer; this is the con¬
figuration maintained during measurement of pressure changes
in the flasks relative to each other.

One may also independently

.«'

..

•

■

.
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vent either chamber to the atmosphere, either directly or
through the manometer.

Each chamber is capped by a poly¬

ethylene stopper pierced by metal cannulas which allow
access for the purposes of displacing the chamber gas by
that under study and of placing cell suspensions into the bot¬
tom of the chamber.
Leak-Lock*,

The stoppers are sealed completely with

a plastic paste sealer9

and the stopcocks are lub¬

ricated with a silicone preparation.
The glass ehffiabers sit in a constant-temperature water

o

o

bath at 27 C (♦ 1 C),

and the remainder of the apparatus is

supported conveniently above.
An atmosphere of halotliane saturated at 21°C is gener¬
ated by a Fcregger Copper Kettle vaporizer

(45).

Simul¬

taneous delivery to each flask through a Y piece ensures
equal concentrations of halothane (32%)

in each chamber.

Calibration of the manometer in cubic centimeters is pre¬
sented in appendix 2.

Procedure

Fresh human red blood cells from the same adult male
volunteer were used for all experiments.

Whole blood was

drawn by venipuncture into a heparinized syringe and then
centrifuged in chemically clean glassware for 15 minutes at
25,000 PPM.

After aspiration of the supernatant plasma and

leukocytes the resulting erythrocytes were thoroughly mixed.
A 2 ml.

aliquot was then pipetted into each of two polyethyl¬

ene syringe tubes which served as mixing and incubation cham¬
bers.

0.50 ml.

of Sorenson’s phosphate buffer (pH 7.38) was

then added to the control aliquot

(appendix 1).

An equal

*A product of Highside Chemicals Inc., Clifton, N.J., which is
soluble in alcohol but resistant to "Freons,-' methyl chloride,
methylene chloride, oil, benzene,
ethylene, CCl^, formaldehyde,

toluene, gasoline, trichoroand water.

t

i

>
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volume of 1,43 M galactose in Sorenson’s buffer was added
to the experimental aliquot.

After thorough mixing the sus¬

pensions were incubated at 15°C in air for one hour (in the
case of those preparations to be exposed to balothane uptake
experiments) or two hours (in the case of those experiments
not exposed to halothane.)
Before the conclusion of the incubation period the atmosphere
in the glass manometer chambers was displaced by a ten-minute
flow of 32% halothane in compressed air.
approximately 300 mm. Hg.

P

^pequalled

The control and experimental eryth¬

rocyte suspensions were then injected into opposite sides of
the manometer: the chambers were then sealed from the surround¬
ing atmosphere simultaneously and connected to the manometer
tube.

Differences in pressure between-the flasks,and therefore

halothane uptake differentials* induced movement of the soap
column until pressure equalization occurred.

Sequential observ¬

ations of the position of the meniscus of a small soap column
were made.
Separate experiments, which will be termed "blanks’* for clarity,
were performed with the same apparatus using red-cell-free
mixtures of water (distilled, ion-free) and either buffer or
buffered galactose.

The volumes of the buffers and the conc¬

entration of the galactose in the sugar buffer were identical
to those stated for the set of experiments containing red

cells.

The water volume was 2.0 cc., equal to that of the packed cells.
Serial determinations of the mlcrohamatocrit were performed
by the Strumia micro method used by Greene.

These were deter¬

mined in packed cells before the addition of buffer, and at
5, 60, and 120 minutes after beginning incubation with buffer
and buffered galactose.
At the conclusion of the experiment the manometer was open¬
ed to the room atmosphere and observed for vigorous movement
of the meniscus away from the opened vent.

This was acusapted

as proof that the internal pressure of the system was sub-
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atmospheric.

Careful attention was paid to maintaining an

air-tight system, and each experiment was preceded by demonst¬
ration of the ability of each chamber to resist a negative
pressure of 0.66 atm., approximately equal to that which would
remain if all halothane was absorbed.

The stopcock was occluded,

and a negative pressure was applied to the flask inlet using
a 3 -ail. displacement of an airtight ground-glass syringe plunger.
Upon release the plunger returned to its original position.
Occasionally the system was subjected to a 60 ram. positive
pressure by similar methods.

The manometer tube joints were

examined occasionally by the same method.

Measurement

1. The volume difference of halothane uptake was taken as
the displacement of the meniscus from its original position
and represented;
Vol.

*

Volume consumption

Blanks were treated similarly.

~

The volume difference was

plotted against time of exposure to halothane on a linear
graph.

2. The hematocrit was observed as described and the mean hematocrits
compared for each of the following four sets*.
1.

incubated in galactose
exposed to halothane.

2.

incubated in buffer
exposed to halothane-

3. incubated in galatose
not exposed to halothane
4. incubated in buffer
not exposed to halothane

iV
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IV.

RESULTS

Halothane uptake

The uptake of halothane by both erythrocytes and red-cellfree buffer solutions was determined.

Figure 3 presents the

results of five independent experiments to determine the vol¬
ume difference between, uptake, in galactose-loaded cells and
uptake in cells exposed to plain buffer.

Figure 4 presents

the results of two independent experiments to determine the
difference betweeh halothane uptake in a mixture of plain
buffer and water and uptake in galactose-loaded buffer and
water.

For convenience, falling lines indicate greater

uptake by the solutionsnot containing galactose, and this id
correlated with shift of the msnfeeter meniscus in a negative
direction as seen in Figure 1.
The *’blank” experiment, using red-cell-free buffer and
sugar, Indicated that galactose alone did not inhibit the up¬
take of halothane in aqueous solution.

Indeed, the volume

of halothane absorbed into galactose solution within twenty
minutes was in one case (c-1) over 0.11 cc. greater than con¬
trol, while in the other case it was 0.05 ce. greater than con¬
trol.
Uptake of halothane by erythrocytes contrasted markedly
to that by cell-free solutions.

Galactose-laden red cells

cosistenly took up less halothane than galactose-free cells.
The volume difference ranged between 0.04 cc.
0.11 cc.

(case 4) and

(case 1) after twenty minutes exposure to halothane.

While the rate of Increase in volume difference appears cons¬
tant for the first ten to twenty minutes, a plateau Is reached
between fifteen (case 5) and fifty (case 2) minutes, indicat¬
ing that uptake has become equal in both galactose-laden and
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galactose-free suspensions.

Two curves

(cases 3 and 3)

show

a. trend toward reversal of the volume difference after forty
to fifty minutes of exposure to halothane.
It is of interest that, three of the five curves in Figure 3
are nearly parallel throughout the first thirty minutes of exp¬
osure .

<
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Galactose uptake

The mean hematocrit© of red cell preparations treated as
described are shown in Table 2 and more complete data are found
in Appendix 3.
The immediate, osmotic effect of the high extracellular galact¬
ose concentration is easily seen in both dets exposed to galactose
(#’s 1 and 3).

These cells occupy less than 0,8 of the vol^sse they

would had they not lost water.
No difference is seen between the sets of galactose-loaded cells
at the end of one hour.

Gradual uptake of galactose and associated

recovery of the water flux is seen in both sets.

Exposure to halothan*

for one hour beyond this time had no effect on galactose transfer.
The sets of erythrocytes placed in phosphate buffer without sugar
shew a slights

(3-4%), but definite increase over the estimated

red-cell volume 5 minutes after Incubation,

The phosphate buffer

used was itself hypotonic (154 « osm./L.) and would be expected to
cause osmotic swelling of the erythrocytes.

The apparent decrease

in the hematocrit at 60 and 120 minutes is not significant.
Figure 2 shows each of these hematocrits as a percentage of
the estimated red cell volume.

Entrance of galactose into the

cell is indicated by the hematocrit changes and this is shown as
a linear function throught the period observed9 indicating satura¬
tion of the membrane carrier.

Hemolysis

Hemolysis was present in all cell suspensions exposed to halothane for one hour.

It was not noted in any suspension before ex¬

posure „ nor did it develop in any suspension not exposed to halothane, regardless of length of incubation in buffer or galactose.
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V. DISCUSSION

These experiments demonstrate s in a seta!-quantitative manner»
that galactose may be a competitive inhibitor of halothane uptake
in red-cell suspension.

Since the observed differences in volume

uptake of halothane were extremely small? much of the support for
this argument must come from the consistency of form displaved*
rather than from any statistical analysis of the data-

It is

obvious from the figures presented that galactose did not inhibit
uptake solely because of its osmotic activity, for uptake was
accelerated in cell-free galactose experiments.

(This may reflect

the baseline of the apparatus, rather than any halothane-binding
effect of galactose* and no other conclusion may be advanced per¬
taining to the cell-free solutions,)
The data presented in Table 2 and Figure 2 demonstrate the
deformation of red cells by osmotic dehydration and rehydration.
This cannot* however, explain the findings in the halothane uptake
experiments, for the red cell deforma without change in its surface
area over a wide range of osmotic pressure© (59)* and the lipid
monolayer area is not increased at low surface pressure© (51),
The increase in extracellular water concomitant with osmotic
dehydration is also an unlikely cause of the greater uptake in
galactose-loaded cells, for it was observed above that halothane
uptake was not increased in aqueous solutions of galactose.
The plateau phase of the curves may be explained in two ways.
Halothane uptake may be decreased in galactose-free solution if
its partial pressure has fallen markedly by this time.

On the

other hand, processes are conceivable whereby the h-alothanepermeated red cell may be. more permeable to further diffusion
(e.g. by alteration of its lipid coating (53,65) or infrastruc¬
tures) .
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The more attractive hypothesis is that galactose-laden red cells
take up halothane at a slower rate than do normal cells, and further
that the rate is dependent on the partial pressure of halothane in
the atmospheric and aqueous phases above the red cells»
of the Lineweaver-Burk plots9

In terms

the initial uptake curves of halo-

thane in the two solutions might generate a similar curve of volume
difference if they proceeded at different rates and were themselves
straight lines.
The data presented in Table 2 for osmotic changes in red-cell
volume differs from that of Greene in that no difference is found
between the rate of galactose transfer in cells exposed to halo¬
thane and those which remain in room air.
incubation in galactose.

This is due to pre-

The excess of galactose places halo¬

thane at a competitive disadvantage, while Greene accomplished
the reverse with an initial excess of halothane.

VI.

SUMMARY

The uptake of halothane in a suspension of red blood cells pre¬
viously incubated for one hour with galactose is less than that in

& native red-cell suspension in phosphate buffer.

Additional ex¬

periments indicate that this Is not due to the osmotic effects of
the galactose molecule, which are also demonstrated.
The literature supporting a carrier-molecule theory of galactose
transfer was reviewed, as was also that pertaining to the inter¬
action of anesthetics and monosaccharides at the cell membrane.
The evidence presented is advanced in support of the theory that
halothane is transferred across erythrocyte membranes in part by
a process competitive with that of galactose transfer.
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Table 1

Characteristics of Halothane:

Formula

CF^ CHBrCl

Boiling point
Vapor pressure

50.2°C
300 ram Hg at 20°C

Heat of vaporization

35 Cal./gm.

Partition coefficients
blood/gas
fat/blood

2.3/1
60/1

brain/blood 2.6/1

Table 2.

#1

n

orig.

92.1

92.2

93.9

94.1

5’

57.3

78.4

59.2

81.3

60’

64.6

77.4

67.8

79.7

120'

74.1

76.8

74.8

79.3

#3

#4

Hct.

i

1'

t.

DiFFEROTAl MAlWnETtFx

Figure 1
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Changes in RBC Volume During
Incubation and Exposure to Halothane
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Figure 4
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Difference in Uptake of Halothane by Buffer
Alone and Buffer with Galactose.
Ihe movement of the meniscus is in a direction op¬
posite that found in the presence of erythrocyte
membranes.

Appendix

1

I. Preparation of s/renson’s Phosphate Buffer

to

)

Stock Solution A (Fifteenth molar KHgPO^)
Dissolve 9.078 gnu monobasic potassium phosphate in
exactly 1000 ml. distilled HpO free of chlorine and
sulfate So
Stock Solution B (Fifteenth molar NagHPO^)
Dissolve 9*472 gm. anhydrous dibasic sodium phosphate
in exactly 1000 ml. distilled HgO free of chlorine and
sulfates.
(Modified from, the original formula which specified
11.876 gm. dibasic sodium -jkosphate with 2 mols water
of hydration added to 1000 ml. RgO.)
Mixture of 2 parts Solution A with 8 parts Solution B
yields phosphate buffer of pH 7*381
II* Preparation of Galactose-Phosphate Buffer Solution
Dissolve.6c441 gm d-Galactose in s/renson's Buffer
end dilute to 25 ml. with the same.

All chemicals used were analytic grade.
water was used for solutions.

Only ion-free distilled

Glassware was chemically clean.

Stock solutions for phosphate buffer were
after the date of preparation.
aiter one week.

used up to.:six.months

Mixed buffer was discarded

Galactose—phosphate buffer solution was

discarded after one week.

Appendix

2.

Callbration of the Manometer Tube
Originally the manometer tube was marked in units
of length (tenths of centimeters.)
Calibration of
the volume markings of the tube was performed by injection
of fluid from a syringe marked in eighty divisions per
cubic centimeter*.
The increments in volume per centimeter
marking are presented below and show no variation in
di ameter of the tubep within limits of accuracy.
Manometer mark
C21c )

5
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
2?
28
29
30

Volume contained
(80th$ of_a„cc.)
Determination $
1
1: 2
j 3
OoO
1c 5
3.0
4.0
5.0
6.0
7.5
9.0
11.0
12.5
13.5
15.0
16.5
18 oO
19.0
20.5
22.0
23.0
24.0
26.0
27.0
28.0
29.5
31.0
32.0
33.0
34.0
35.0

0.0
1.0
2.0
4.0
5.0
6.0
7.5
9.0
10.0
11.5
12.5
14.0
15.5
17.0
18.0
19.5
21.0
22.0
23.5
25.0

26.0
27.5
29.0
30.0
31.5
32.5
34„0
35.5

0.0
1.0
2.5
4,0
5.0
6.5
8.0
9.0
10,5
12.0
13.0
14.0
15.5
17.0
18.5
19.5
21.0
22.0
23.5
25.0
26.0
27.5
29.0

30.0
31.5
32.5
34.0
35,5

Thus there are 35« 33/80 sc. per 27*0 cmV length, and
on
Dm. contains 0,0164 cubic centim iters.
Experimental
reading were taken on the centimeter scale. nd^translated
to cubic centimeters by the formula:
cubic centimeters»(centimeter reading' ^3} x Do0164

1

:

■
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Appendix

3,

Hematocrit Determinations
(Each experimental value listed ia the mean of four or more
simultaneous .determinations.)

r.r

2

S.x eerimeni
4
3
j
1

Me an
i

5

92.9

91.8

92p 2

91.6

91.9

92.1

56.9

58.6

55.8

57.8

57.6

57.3

62. 5

62.4

63.7

67.8

66.6

64.6

72.8

73.6

74. 2

75.1

74.7

74.1

92.6

91.8

92.6

91.8

92.0

92.2

76.8

77.0

79.7

79.5

79.0

78.4

76.7

75.4

78.0

78.0

78.9

77.4

77.4

76.7

76.9

76.1

76.8

76.8

S-ir.W^.A *>.S/

95.5

94.0

94.2

93.9

56.9

60„3

60.4

59.2

66.3

70.8

66,4

67.8

70.7

77.8

75.8

74.8

93.7

94.1

94.6

94.1

79.1

82.8

82.0

61.3

78.1

80.8

80.1

79.7

78.8

80.5

78.9

79.3
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